MODERN APPROACH TO TREATMENT OF THE UPPER RESPIRATORY TRACT AND MIDDLE EAR DISEASES AS A PREVENTION OF LOSS HEARING
https://doi.org/10.15690/pf.v9i1.162
Abstract
About the Authors
O. V. KarneevaD. P. Polyakov
References
1. Ear and Hearing Disorders Survey Protocol and Package. WHO. 2010.
2. Zagoryanskaya ME, Rumyantseva MG, LB Dainiak Hearing impairment in children: an epidemiological study. Journal of otorhinolaryngology. 2003, 6: 7-10.
3. Tarasova, GD Age characteristics of antibiotic therapy for acute otitis media. Russian otorhinolaryngology. 2004, 4 (11): 77-81.
4. Tos M. Manual of Middle Ear Surgery. New York. 1995, 2: 412.
5. Dmitriev, NS, Mileshina NA Kolesov L. Exudative otitis media: Guidelines. Moscow. In 1996. 26 s.
6. Preobrazhensky, NA Hearing loss. Moscow: Medicine. In 1978. 438 p.
7. Williamson I. Otitis media with effusion in children. Clin Evid (Online). 2011. pii:0502.
8. Karneeva OV Polyakov, DP, EI Zelikovich Modern diagnostics and surgical treatment of combined pathology of the middle ear and nasopharynx in children. Russian otorhinolaryngology. 2008, 2: 47-51.
9. Aparna M.S., Yadav S. Biofilms: microbes and disease. Braz J Infect Dis. 2008, 12 (6): 526-30.
10. Torretta S. et al. Diagnostic accuracy of nasopharyngeal swabs in detecting biofilmprodusing bacteria in chronic adenoditis: a preliminary study. Otolaryngol Head Neck Surg. 2011, 144 (5): 784-8.
11. Hindenbrand T. Nasal douching in acute rhinosinusitis. Laryngorhinootologie. 2011, 90 (6): 346-51.
12. Shaikh N., Wald E.R., Pi M. Decongestants, antihistamines and nasal irrigation for acute sinusitis in children. Cochrane Database Syst Rev. 2010; (12): CD007909.
13. Coleman C., Moore M. Decongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev. 2008, 16 (3): CD001727.
14. Iskhaki JB, LI Kalshteyn Children's Otolaryngology. Dushanbe. In 1984. 398p.
15. Kolodiy EL, OB Brodovskaya The use of mucolytics in the treatment of some ACC ENT diseases. Journal of otorhinolaryngology. 2004, 3: 48-49.
16. Instructions for medical use of the drug Fluimutsil ®.
17. Aslam S., Darouiche R.O. Role of antibiofilm-antimicrobal agents in controlling devicerelated infections. Int J Artif Organs. 2011; 34 (9): 752-8.
18. Cogo A. et al. Efficacy of topical tuaminoheptane combined with N-acetyl-cysteine in reducing nasal resistance. A double-blind rhinomanometric study versus xylometazolinne and placebo. Arzneimittelforschung. 1996, 46 (4): 385-8.
19. Serra A. et al. A therapeutic approach in the treatment of infections of the upper airways: thiamphenicol glycinate acetylcysteinate in sequential treatment (systemic-inhalatory route). Int J Immunopathol Pharmacol. 2007; 20 (3): 607-17.
20. Smith A., Buchinsky F.J., Post J.C. Eradicating chronic ear, nose, and throat infections: a systematically conducted literature review of advances in biofilm treatment. Otolaryngol Head Neck Surg. 2011; 144 (3): 338-47.
Review
For citations:
Karneeva O.V., Polyakov D.P. MODERN APPROACH TO TREATMENT OF THE UPPER RESPIRATORY TRACT AND MIDDLE EAR DISEASES AS A PREVENTION OF LOSS HEARING. Pediatric pharmacology. 2012;9(1):30-34. https://doi.org/10.15690/pf.v9i1.162